Download FREE Report Sample
Download Free sampleGene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Gene Therapy Neurological Diseases Market contains market size and forecasts of Gene Therapy on Neurological Diseases in Global, including the following market information:
Global Gene Therapy on Neurological Diseases Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gene Therapy on Neurological Diseases market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Viral Gene Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gene Therapy on Neurological Diseases include Biogen, Novartis and Sarepta Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapy on Neurological Diseases companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy on Neurological Diseases Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gene Therapy on Neurological Diseases Market Segment Percentages, by Type, 2021 (%)
Viral Gene Therapy
Non-viral Gene Therapy
Global Gene Therapy on Neurological Diseases Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gene Therapy on Neurological Diseases Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Gene Therapy on Neurological Diseases Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gene Therapy on Neurological Diseases Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy on Neurological Diseases revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gene Therapy on Neurological Diseases revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Novartis
Sarepta Therapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
